Syntara LimitedASX: SNT

Placement

· Issued by Syntara Limited

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Syntara Limited has announced a placement to raise funds for clinical trials and drug development, receiving strong support from investors. The funds will support various clinical trials and general working capital needs. Syntara's CEO expressed gratitude for the investor support following positive interim results from a recent study.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Syntara Limited on 6ix

In the deck

Earlier from Syntara

Later from Syntara

All Syntara news releases